Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Roca

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Anti-Cancer Drugs|July 17, 2010
A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinomaJen-Shi Chen, Yee Chao, Yung-Jue Bang, et al.
International Journal of Cancer|January 30, 2019
Lynch-like syndrome is as frequent as Lynch syndrome in early-onset nonfamilial nonpolyposis colorectal cancerMarina Antelo, Mariano Golubicki, Enrique Roca, et al.
Familial Cancer|March 17, 2015
Pitfalls in the diagnosis of biallelic PMS2 mutationsMarina Antelo, Daniela Milito, Jennifer Rhees, et al.
Cancers|April 3, 2021
Comprehensive Genomic Characterization of Fifteen Early-Onset Lynch-Like Syndrome Colorectal CancersMariano Golubicki, Marcos Díaz-Gay, Laia Bonjoch, et al.
Biomedicines|March 29, 2023
Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric CohortSoledad Iseas, Diego Prost, Sarah Bouchereau, et al.
Translational Oncology|March 31, 2021
A clinical and molecular portrait of non-metastatic anal squamous cell carcinomaSoledad Iseas, Mariano Golubicki, Juan Robbio, et al.
The Lancet. Gastroenterology & Hepatology|September 29, 2018
Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trialAlvaro Romera, Sergiy Peredpaya, Yaroslav Shparyk, et al.
Cancers|August 14, 2020
Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal CancerJuan M Sendoya, Soledad Iseas, Mariana Coraglio, et al.
JCI Insight|August 26, 2020
Germline biallelic Mcm8 variants are associated with early-onset Lynch-like syndromeMariano Golubicki, Laia Bonjoch, José G Acuña-Ochoa, et al.
Frontiers in Oncology|January 24, 2022
Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal CancerSoledad Iseas, Juan M Sendoya, Juan Robbio, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Anti-Cancer Drugs|July 17, 2010
A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinomaJen-Shi Chen, Yee Chao, Yung-Jue Bang, et al.
International Journal of Cancer|January 30, 2019
Lynch-like syndrome is as frequent as Lynch syndrome in early-onset nonfamilial nonpolyposis colorectal cancerMarina Antelo, Mariano Golubicki, Enrique Roca, et al.
Familial Cancer|March 17, 2015
Pitfalls in the diagnosis of biallelic PMS2 mutationsMarina Antelo, Daniela Milito, Jennifer Rhees, et al.
Cancers|April 3, 2021
Comprehensive Genomic Characterization of Fifteen Early-Onset Lynch-Like Syndrome Colorectal CancersMariano Golubicki, Marcos Díaz-Gay, Laia Bonjoch, et al.
Biomedicines|March 29, 2023
Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric CohortSoledad Iseas, Diego Prost, Sarah Bouchereau, et al.
Translational Oncology|March 31, 2021
A clinical and molecular portrait of non-metastatic anal squamous cell carcinomaSoledad Iseas, Mariano Golubicki, Juan Robbio, et al.
The Lancet. Gastroenterology & Hepatology|September 29, 2018
Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trialAlvaro Romera, Sergiy Peredpaya, Yaroslav Shparyk, et al.
Cancers|August 14, 2020
Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal CancerJuan M Sendoya, Soledad Iseas, Mariana Coraglio, et al.
JCI Insight|August 26, 2020
Germline biallelic Mcm8 variants are associated with early-onset Lynch-like syndromeMariano Golubicki, Laia Bonjoch, José G Acuña-Ochoa, et al.
Frontiers in Oncology|January 24, 2022
Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal CancerSoledad Iseas, Juan M Sendoya, Juan Robbio, et al.
Pageof 4